Our website is set to 'allow cookies' to give you the best experience without telling us who you are. Please continue if you consent to this, or click below to change your settings:
Find out more about our cookies policy
(+1) 617 896 0213
info@sagentia.com
Our track record is built on knowledge and expertise in the global medical, industrial and consumer market sectors. With offices in Europe and the USA, we can work with you wherever you are.
The global healthcare sector is facing continued pressure to demonstrate greater health effectiveness and improved cost efficiency of all new products and procedures. With the combination of financial cutbacks, regulatory and reimbursement changes, evolving user characteristics and the transition towards connected health, medical device manufacturers need to deliver value based innovation for their products and services to stay ahead.
At Sagentia we work across the boundaries of the patient care continuum, identifying and developing innovative surgical, diagnostic and patient care devices and systems. With a year track record of more than 27 years in the industry, we know the importance of combining science, technology, engineering and user focused design to solve difficult R&D challenges and we are well placed to help medical device companies respond to the industry’s challenges. We work with clients from front end innovation and market needs analysis, through detailed design and product development, to transfer to manufacture. Many of our medical device developments also include complex software development, which is one of our core capabilities.
We’ve delivered innovation and value to a wide range of clients including: Johnson & Johnson, AstraZeneca, Smith & Nephew, Alere, St Jude Medical, T2 Biosystems, Titan and Photocure.
Experts in complex science & technology Multidisciplinary, cross sector team approach Excel at meeting aggressive timescales Customer friendly approach to IP Accreditation to ISO9001:2008 and ISO13485:2003 What our clients say: "We have worked with Sagentia on a number of issues. The reason in every case is their ability to deliver innovative engineering and then deliver on execution."